Literature DB >> 8892956

Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.

N Jarousse1, C Martinat, S Syan, M Brahic, A McAllister.   

Abstract

Following intracranial inoculation, Theiler's virus causes either an acute encephalitis (strain GDVII) or a chronic demyelinating disease (strain DA). The DA strain sequentially infects the grey matter of the brain, the grey matter of the spinal cord, and, finally, the white matter of the spinal cord, where it persists in glial cells and causes demyelinating lesions. Analysis of the phenotype of recombinant viruses has shown that the viral capsid contains determinants for persistence and demyelination. Our previous studies showed that a Lys at position 141 of the VP2 capsid protein (VP2-141) could render a chimeric virus persistent. We also reported that another recombinant virus, virus R5, migrated from the grey matter of the brain to that of the spinal cord inefficiently and was unable to infect the white matter of the spinal cord. In this article, we report that introducing a Lys at position VP2-141 in virus R5 increases its ability to infect the white matter of the spinal cord. Our results indicate that this amino acid is important for the spread of the virus within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892956      PMCID: PMC190905     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.

Authors:  A Senkowski; B Shim; R P Roos
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

2.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses.

Authors:  D C Pevear; M Calenoff; E Rozhon; H L Lipton
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  The atomic structure of Mengo virus at 3.0 A resolution.

Authors:  M Luo; G Vriend; G Kamer; I Minor; E Arnold; M G Rossmann; U Boege; D G Scraba; G M Duke; A C Palmenberg
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

5.  Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses.

Authors:  Y Ohara; A Senkowski; J L Fu; L Klaman; J Goodall; M Toth; R P Roos
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.

Authors:  R P Roos; S Stein; M Routbort; A Senkowski; T Bodwell; R Wollmann
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.

Authors:  C Aubert; M Chamorro; M Brahic
Journal:  Microb Pathog       Date:  1987-11       Impact factor: 3.738

9.  Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses.

Authors:  Y Ohara; S Stein; J L Fu; L Stillman; L Klaman; R P Roos
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

10.  Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.

Authors:  D C Pevear; J Borkowski; M Calenoff; C K Oh; B Ostrowski; H L Lipton
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

View more
  8 in total

1.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Distinct attenuation phenotypes caused by mutations in the translational starting window of Theiler's murine encephalomyelitis virus.

Authors:  E V Pilipenko; E G Viktorova; E V Khitrina; S V Maslova; N Jarousse; M Brahic; V I Agol
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.

Authors:  I J McCright; I Tsunoda; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.

Authors:  E E Fry; S M Lea; T Jackson; J W Newman; F M Ellard; W E Blakemore; R Abu-Ghazaleh; A Samuel; A M King; D I Stuart
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

6.  Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line.

Authors:  X Lin; S Sato; A K Patick; L R Pease; R P Roos; M Rodriguez
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 7.  Borna disease virus and the brain.

Authors:  D Gonzalez-Dunia; C Sauder; J C de la Torre
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

Review 8.  Viral mouse models used to study multiple sclerosis: past and present.

Authors:  J E Libbey; R S Fujinami
Journal:  Arch Virol       Date:  2021-02-13       Impact factor: 2.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.